Logo image of ACMR

ACM RESEARCH INC-CLASS A (ACMR) Stock Fundamental Analysis

USA - NASDAQ:ACMR - US00108J1097 - Common Stock

29.86 USD
-0.24 (-0.8%)
Last: 9/12/2025, 8:00:00 PM
30.0899 USD
+0.23 (+0.77%)
After Hours: 9/12/2025, 8:00:00 PM
Fundamental Rating

5

Overall ACMR gets a fundamental rating of 5 out of 10. We evaluated ACMR against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. There are concerns on the financial health of ACMR while its profitability can be described as average. ACMR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year ACMR was profitable.
In the past year ACMR had a positive cash flow from operations.
In the past 5 years ACMR has always been profitable.
In the past 5 years ACMR reported 4 times negative operating cash flow.
ACMR Yearly Net Income VS EBIT VS OCF VS FCFACMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

The Return On Assets of ACMR (5.50%) is better than 72.32% of its industry peers.
With a decent Return On Equity value of 11.37%, ACMR is doing good in the industry, outperforming 75.89% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 8.31%, ACMR is in the better half of the industry, outperforming 77.68% of the companies in the same industry.
ACMR had an Average Return On Invested Capital over the past 3 years of 7.59%. This is below the industry average of 10.87%.
The 3 year average ROIC (7.59%) for ACMR is below the current ROIC(8.31%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.5%
ROE 11.37%
ROIC 8.31%
ROA(3y)4.65%
ROA(5y)4.61%
ROE(3y)9.12%
ROE(5y)9.25%
ROIC(3y)7.59%
ROIC(5y)6.61%
ACMR Yearly ROA, ROE, ROICACMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400 500

1.3 Margins

The Profit Margin of ACMR (13.75%) is better than 74.11% of its industry peers.
In the last couple of years the Profit Margin of ACMR has declined.
ACMR has a better Operating Margin (17.87%) than 76.79% of its industry peers.
In the last couple of years the Operating Margin of ACMR has grown nicely.
ACMR has a better Gross Margin (49.40%) than 61.61% of its industry peers.
In the last couple of years the Gross Margin of ACMR has remained more or less at the same level.
Industry RankSector Rank
OM 17.87%
PM (TTM) 13.75%
GM 49.4%
OM growth 3Y9.03%
OM growth 5Y3.12%
PM growth 3Y-3.07%
PM growth 5Y-5.5%
GM growth 3Y4.22%
GM growth 5Y1.2%
ACMR Yearly Profit, Operating, Gross MarginsACMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACMR is destroying value.
ACMR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ACMR has more shares outstanding
Compared to 1 year ago, ACMR has a worse debt to assets ratio.
ACMR Yearly Shares OutstandingACMR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACMR Yearly Total Debt VS Total AssetsACMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.54 indicates that ACMR is not a great score, but indicates only limited risk for bankruptcy at the moment.
ACMR has a Altman-Z score (2.54) which is in line with its industry peers.
ACMR has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
ACMR has a Debt to Equity ratio (0.22) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 2.54
ROIC/WACC0.74
WACC11.2%
ACMR Yearly LT Debt VS Equity VS FCFACMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

ACMR has a Current Ratio of 2.45. This indicates that ACMR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.45, ACMR is in line with its industry, outperforming 40.18% of the companies in the same industry.
A Quick Ratio of 1.49 indicates that ACMR should not have too much problems paying its short term obligations.
ACMR's Quick ratio of 1.49 is on the low side compared to the rest of the industry. ACMR is outperformed by 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 1.49
ACMR Yearly Current Assets VS Current LiabilitesACMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

6

3. Growth

3.1 Past

ACMR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.80%.
The Earnings Per Share has been growing by 42.35% on average over the past years. This is a very strong growth
The Revenue has grown by 17.53% in the past year. This is quite good.
The Revenue has been growing by 48.72% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)5.8%
EPS 3Y52.55%
EPS 5Y42.35%
EPS Q2Q%-1.82%
Revenue 1Y (TTM)17.53%
Revenue growth 3Y44.39%
Revenue growth 5Y48.72%
Sales Q2Q%6.37%

3.2 Future

Based on estimates for the next years, ACMR will show a small growth in Earnings Per Share. The EPS will grow by 1.96% on average per year.
The Revenue is expected to grow by 16.65% on average over the next years. This is quite good.
EPS Next Y-3.8%
EPS Next 2Y1.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year21.34%
Revenue Next 2Y18.6%
Revenue Next 3Y18.8%
Revenue Next 5Y16.65%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ACMR Yearly Revenue VS EstimatesACMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
ACMR Yearly EPS VS EstimatesACMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

ACMR is valuated correctly with a Price/Earnings ratio of 13.63.
Based on the Price/Earnings ratio, ACMR is valued cheaply inside the industry as 95.54% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.30. ACMR is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 12.71, which indicates a correct valuation of ACMR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACMR indicates a rather cheap valuation: ACMR is cheaper than 93.75% of the companies listed in the same industry.
ACMR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.63
Fwd PE 12.71
ACMR Price Earnings VS Forward Price EarningsACMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

ACMR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ACMR is cheaper than 91.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.18
ACMR Per share dataACMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The decent profitability rating of ACMR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.32
EPS Next 2Y1.96%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ACMR!.
Industry RankSector Rank
Dividend Yield N/A

ACM RESEARCH INC-CLASS A

NASDAQ:ACMR (9/12/2025, 8:00:00 PM)

After market: 30.0899 +0.23 (+0.77%)

29.86

-0.24 (-0.8%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners69.39%
Inst Owner Change2.64%
Ins Owners5.53%
Ins Owner Change-4.16%
Market Cap1.91B
Analysts81.43
Price Target37.04 (24.05%)
Short Float %8.07%
Short Ratio3.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.05%
Min EPS beat(2)5.36%
Max EPS beat(2)22.75%
EPS beat(4)4
Avg EPS beat(4)33.95%
Min EPS beat(4)5.36%
Max EPS beat(4)65.81%
EPS beat(8)8
Avg EPS beat(8)56.84%
EPS beat(12)12
Avg EPS beat(12)939.34%
EPS beat(16)15
Avg EPS beat(16)715.5%
Revenue beat(2)1
Avg Revenue beat(2)-1.65%
Min Revenue beat(2)-5.49%
Max Revenue beat(2)2.19%
Revenue beat(4)3
Avg Revenue beat(4)3.43%
Min Revenue beat(4)-5.49%
Max Revenue beat(4)12.4%
Revenue beat(8)6
Avg Revenue beat(8)5.81%
Revenue beat(12)10
Avg Revenue beat(12)7.93%
Revenue beat(16)12
Avg Revenue beat(16)7.41%
PT rev (1m)2.06%
PT rev (3m)3.91%
EPS NQ rev (1m)-11.02%
EPS NQ rev (3m)-12.89%
EPS NY rev (1m)-5.58%
EPS NY rev (3m)-5.06%
Revenue NQ rev (1m)-0.31%
Revenue NQ rev (3m)0.47%
Revenue NY rev (1m)-0.65%
Revenue NY rev (3m)-0.24%
Valuation
Industry RankSector Rank
PE 13.63
Fwd PE 12.71
P/S 2.34
P/FCF N/A
P/OCF 31.35
P/B 1.93
P/tB 1.94
EV/EBITDA 10.18
EPS(TTM)2.19
EY7.33%
EPS(NY)2.35
Fwd EY7.87%
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)0.95
OCFY3.19%
SpS12.76
BVpS15.45
TBVpS15.4
PEG (NY)N/A
PEG (5Y)0.32
Profitability
Industry RankSector Rank
ROA 5.5%
ROE 11.37%
ROCE 10.64%
ROIC 8.31%
ROICexc 12.74%
ROICexgc 12.78%
OM 17.87%
PM (TTM) 13.75%
GM 49.4%
FCFM N/A
ROA(3y)4.65%
ROA(5y)4.61%
ROE(3y)9.12%
ROE(5y)9.25%
ROIC(3y)7.59%
ROIC(5y)6.61%
ROICexc(3y)11.47%
ROICexc(5y)11.39%
ROICexgc(3y)11.51%
ROICexgc(5y)11.42%
ROCE(3y)9.71%
ROCE(5y)8.55%
ROICexcg growth 3Y8.64%
ROICexcg growth 5Y4.84%
ROICexc growth 3Y8.55%
ROICexc growth 5Y4.8%
OM growth 3Y9.03%
OM growth 5Y3.12%
PM growth 3Y-3.07%
PM growth 5Y-5.5%
GM growth 3Y4.22%
GM growth 5Y1.2%
F-Score4
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA 1.37
Cap/Depr 671.56%
Cap/Sales 9.59%
Interest Coverage 25.35
Cash Conversion 38.68%
Profit Quality N/A
Current Ratio 2.45
Quick Ratio 1.49
Altman-Z 2.54
F-Score4
WACC11.2%
ROIC/WACC0.74
Cap/Depr(3y)1126.77%
Cap/Depr(5y)1047%
Cap/Sales(3y)15.44%
Cap/Sales(5y)11.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.8%
EPS 3Y52.55%
EPS 5Y42.35%
EPS Q2Q%-1.82%
EPS Next Y-3.8%
EPS Next 2Y1.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.53%
Revenue growth 3Y44.39%
Revenue growth 5Y48.72%
Sales Q2Q%6.37%
Revenue Next Year21.34%
Revenue Next 2Y18.6%
Revenue Next 3Y18.8%
Revenue Next 5Y16.65%
EBIT growth 1Y21.83%
EBIT growth 3Y57.43%
EBIT growth 5Y53.36%
EBIT Next Year11.61%
EBIT Next 3Y13.48%
EBIT Next 5Y11.92%
FCF growth 1Y87.13%
FCF growth 3YN/A
FCF growth 5Y51.73%
OCF growth 1Y342.07%
OCF growth 3YN/A
OCF growth 5Y74.58%